These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 544292)

  • 1. Toxicity of factor IX concentrates in mice.
    Magner A; Aronson D
    Dev Biol Stand; 1979; 44():185-8. PubMed ID: 544292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
    J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gel filtration properties of factors II, VII, IX, IX a , and X.
    Osterud B; Schiffman S
    Thromb Diath Haemorrh; 1972 Oct; 28(2):317-24. PubMed ID: 4629507
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the prothrombin complex, II. Behavior of prothrombin, factor VII, IX and X during column chromatography on anion exchangesRS].
    Voss D
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1172-8. PubMed ID: 5588277
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of ethanol feeding on the activities of factors II, VII, VIII, IX and X in rats.
    Morland J; Holm T; Prydz H
    Thromb Haemost; 1976 Dec; 36(3):532-6. PubMed ID: 1037150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro investigation of prothrombin complex concentrates.
    Römisch J; Bonik K; Müller HG
    Semin Thromb Hemost; 1998; 24(2):175-81. PubMed ID: 9579640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and clinical use of factor IX concentrate PPSB according to Soulier.
    Haanen C; McShine RL; Kunst A
    Vox Sang; 1969 Apr; 16(4):398-411. PubMed ID: 5800593
    [No Abstract]   [Full Text] [Related]  

  • 8. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
    Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
    Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
    Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
    Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulants.
    Forbes CD; Prentice CR
    Practitioner; 1974 Oct; 213(1276 SPEC NO):470-7. PubMed ID: 4617204
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
    Kelly P; Penner JA
    JAMA; 1976 Nov; 236(18):2061-4. PubMed ID: 989788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate.
    Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Santagostino E; Tradati FC; Rosenberg RD
    Br J Haematol; 1991 Dec; 79(4):606-11. PubMed ID: 1772782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation in cephalhaematomas.
    Ströder J; Mingers AM
    Z Kinderheilkd; 1974; 116(4):153-61. PubMed ID: 4825915
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of blood clotting factor activity in PPSB].
    Tarasova LN; Saltykova ZA
    Vopr Med Khim; 1974; 20(4):440-2. PubMed ID: 4462299
    [No Abstract]   [Full Text] [Related]  

  • 15. [Longitudinal study of factors X, IX, VIII, V, II and I in the first 6 months of life].
    Duvina PL; Simoni MR; Pezzati M; Poggi G; Rosati C; Trampi F; Duvina G
    Minerva Pediatr; 1987 May; 39(10):421-36. PubMed ID: 3116376
    [No Abstract]   [Full Text] [Related]  

  • 16. Separation of blood coagulation factors II, VII, IX and X by gel filtration in the presence of dextran blue.
    Swart AC; Hemker HC
    Biochim Biophys Acta; 1970 Dec; 222(3):692-5. PubMed ID: 5496498
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence against vitamin K deficiency in normal neonates.
    Malia RG; Preston FE; Mitchell VE
    Thromb Haemost; 1980 Dec; 44(3):159-60. PubMed ID: 7466743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of hepatitis B surface antigen (HBsAg) from plasma fractions.
    Johnson AJ; Semar M; Newman J; Harris RB; Brandt D; Middleton S; Smith J
    J Lab Clin Med; 1976 Jul; 88(1):91-101. PubMed ID: 932537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin.
    Prowse CV; Boffa MC; Guthrie C; Pepper DS
    Thromb Haemost; 1980 Feb; 42(5):1368-77. PubMed ID: 7368144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A true hypercoagulability state in patients on chronic hemodialysis.
    Erickson RV; Williman M; Pendras JP
    Trans Am Soc Artif Intern Organs; 1966; 12():205-6. PubMed ID: 5960704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.